CBD
24
3
6
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
1 terminated out of 24 trials
90.0%
+3.5% vs benchmark
8%
2 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (24)
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
CBD-Microglia PET Study
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RCT of CBD for Anxiety in Advanced Breast Cancer
Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
Is Topical CBD Effective in Treating Thumb Joint Arthritis
Cannabidiol and Management of Endometriosis Pain
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
Cannabidiol, Morphine, Pain
Sex Differences in Neural Response to Cannabidiol
Effects of Cannabidiol (CBD) on the Brain
CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)
EMERALD TRIAL Open Label Extension Study
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
The Use of Cannabinoid Patch for Knee Osteoarthritis
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm